Email Newsletters

Harvard Bioscience Inc.

Harvard Bioscience up 20% as firm looks to restructure

Harvard Bioscience opened the stock market on Friday trending up more than 20% after its second-quarter earnings reflected an improved financial condition as the company focuses on improving its underlying performance. 

Harvard Bioscience replaces CEO Duchemin with chairman

Holliston life science equipment manufacturer Harvard Bioscience has replaced President and CEO Jeffrey Duchemin with four-year director James Green. 

Harvard Bioscience executive quits

The top executive for sales at Holliston life science researcher Harvard Bioscience has resigned during an overhaul of the company's sales team to focus on areas with higher growth potential, according to regulatory filings.

Harvard Bio reports 7% sales rise in second quarter

<i>(UPDATED Friday, July 31 to correct company name)</i> Holliston-based Harvard Bioscience reported Thursday that the second quarter of 2015 saw revenue rise to $28.8 million.
- Advertisement -

Jeffrey Duchemin – President and CEO, Harvard Bioscience

There is a science to the work of Harvard Bioscience CEO Jeffrey Duchemin. And acquisitions are an...

‘Disappointing’ quarter for Harvard Bioscience

Harvard Bioscience of Holliston reported a $1.4 million loss amid lower first-quarter revenues of $25.8 million, a slight drop of about 0.5 percent from $25.9 million in the same period of 2014, the life sciences manufacturer said.

Harvard Apparatus changes leadership

The CEO at biotech firm Harvard Apparatus Regenerative Technology (HART) of Holliston has resigned, replaced on an interim basis by CFO Thomas McNaughton, the company announced.

Harvard Apparatus reports ‘significant progress’

Holliston-based Harvard Apparatus Regenerative Technology, or HART, reported Thursday that the company had revenue of $45,000 in the fourth quarter of 2014 from the sale of bioreactor systems for organ regeneration research. That was more than double the $22,000 in revenue for the same period in 2013.
- Advertisement -

‘Fulfilling, exciting’ year for Harvard Bioscience

Harvard Bioscience of Holliston reported record quarterly revenues of $30.4 million in the fourth quarter of 2014.

Holliston biotech closes public offering

Biotech firm Harvard Apparatus Regenerative Technology of Holliston has closed a previously announced public stock offering after raising about $8.6 million, the company announced this week.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Quality Engineer II – Columbia Tech

Columbia Tech
,
Westborough, MA

Production Manager – Columbia Tech

Columbia Tech
,
Westborough, MA

Chief Financial Officer

The Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$125,000 - $135,000
More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA